Drawing for EYETEC

USPTO serial 79435332

EYETEC

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
BLAZICH, JOAN MICHELE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with EYETEC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joseph Sofer

Joseph Sofer Ipsilon USA, LLP110 West 40th street, Suite 2001Suite 2001New York, NY 10018

Goods and services

ClassDescriptionStatusFirst use
035Retail and wholesale distributorship services featuring pharmaceutical manufacturing and laboratory equipment; retail and wholesale distributorship services featuring leak test samples and particle test samples for use in qualifying container closure integrity testing (CCIT) and visual inspection equipment; procurement services for others, namely, purchasing pharmaceutical manufacturing and laboratory equipment, leak test samples, and particle test samples for other businesses in the pharmaceutical industryACTIVE—
037Installation, maintenance and repair of pharmaceutical manufacturing and laboratory machines, namely, GMP washing machines and autoclaves; installation, maintenance and repair of visual inspection machines; installation, maintenance and repair of leak test machines and container closure integrity testing (CCIT) machines; installation, maintenance and repair of optical instruments used for visual inspection of pharmaceuticals and pharmaceutical packagingACTIVE—
042Technical inspection services for pharmaceutical manufacturing and laboratory equipment for quality control purposes; inspection of pharmaceuticals and pharmaceutical packaging for quality control purposes; technology supervision and inspection of pharmaceutical manufacturing and laboratory equipment; inspection of goods, namely, pharmaceuticals and pharmaceutical packaging components, for quality control purposes; container closure integrity testing for pharmaceutical packaging; calibration and function testing of measuring apparatus used in pharmaceutical manufacturing and laboratory environments; engineering services, namely, process engineering and technical consultancy in the field of visual inspection and container closure integrity testing (CCIT) for pharmaceuticals; scientific industrial analysis and research services in the field of pharmaceutical manufacturing quality control, including visual inspection and container closure integrity testing; quality control and authentication services in the field of pharmaceutical manufacturing; technical project studies being engineering services and technical research in the field of pharmaceutical manufacturing equipment and laboratory equipmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 29, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 29, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 23, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 31, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 21, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 21, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Aug 21, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 21, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 4, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 4, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 4, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 26, 2026RFNTREFUSAL PROCESSED BY IB—
Feb 6, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 6, 2026RFRRREFUSAL PROCESSED BY MPU—
Jan 13, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 12, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 6, 2026DOCKASSIGNED TO EXAMINER—
Oct 27, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 27, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 23, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance